International Explained: Moderna's Cancer And Heart Vaccines Could Be Made By 2030, What's Science Behind Them? BY Madhur Sharma
International USA: Florida's Top Health Official Advises Against Covid mRNA Vaccines, Cites High Risk Of Heart Side Effects BY Outlook News Desk
National Gennova Biopharmaceuticals Is Ready To Roll Out 70 Lakh Doses Of Its Gemcovac-19 vaccine BY PTI
International Fourth Vaccine Dose Protects Elderly From COVID-19 But Protection Wanes Quickly: Study BY Outlook News Desk
National Japan PM, Pfizer CEO Hold Call To Expedite Covid-19 Booster Dose Supply BY Outlook News Desk
Making A Difference Covid-19 Vaccines: US CDC Panel Recommends Pfizer, Moderna Over J&J Shot BY Outlook News Desk
Making A Difference Omicron Variant: South Africa Develops Indigenous Covid-19 Vaccine BY Outlook News Desk
Making A Difference Omicron Covid-19 Variant Expected To Be Dominant By Mid January: EU Official BY Outlook News Desk
Making A Difference Covid-19: Pfizer Vaccine Not Effective Against Omicron Like Delta, Finds South Africa Analysis BY Outlook News Desk
miscellaneous Children Must Be Vaccinated If Supplies Are Sufficient, Says Expert BY Outlook News Desk
Making A Difference US Regulators Approve Covid-19 Vaccine Boosters For All Adults BY Outlook News Desk
National Covaxin Gets WHO Nod For Emergency Use: What That Means For Indian Travelers BY Outlook News Desk
Making A Difference Covid-19: US Gives Final Vaccine Clearance For Children 5 To 11 BY Deutsche Welle
Making A Difference US: 5 To 11-Year-Old Kids May Get Covid-19 Vaccine Soon As FDA Panel Endorses Pfizer Shots BY Associated Press
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
.png?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
